Macrophages are activated by bacterial lipopolysaccharide (LPS) to produce inflammatory cytokines such as TNF-α or reactive oxygen species such as nitric oxide or superoxide anion. However, in the presence of an inhibitor of protein synthesis, cycloheximide (CHX), at 10 μg/mL, LPS at 100 μg/mL induced macrophage apoptosis rapidly without producing phenotypes of activated macrophages. In order to understand the mechanism underlying LPSinduced cytotoxicity toward macrophages, we isolated mutant cells from a macrophage-like cell line, J774.1, as clones resistant against the cytotoxic effects of LPS + CHX by using a somatic cell genetics protocol. All of the mutant clones, designated as LCR mutants, showed resistance to the cell death induced by LPS + CHX as well as to that induced by higher doses of LPS alone, as did the LPS1916 mutant cell line, which had been previously established by its resistance to 100 μg/mL LPS. Characterization of the activated macrophage phenotypes revealed that these mutants showed reduced production of TNF-α and nitric oxide in response to LPS. Further analysis showed a much reduced amount of [ 
INTRODUCTION
Macrophages are known to be activated by bacterial lipopolysaccharides (LPS; [1, 2] ), and the activated macrophages produce reactive oxygen species (ROS) such as superoxide anion ( 2 ), hydrogen peroxide (H 2 O 2 ), and nitric oxide (NO), or prostaglandins and inflammatory cytokines such as TNF-α, IL-1β, and so on [3, 4] . It is also known that high concentrations of LPS lead to macrophage dysfunction and death [5, 6] probably through certain products from such activated macrophages [6, 7] . In macrophages, expression of LPS binding due to lymphokines or gamma interferon (IFN-γ) seems to be closely correlated with the LPS-induced cytotoxic effects of macrophages toward tumor cells [8] . However, little is known about the precise mechanisms underlying these cytotoxic effects of LPS on macrophages. To elucidate the mechanisms of the LPS action on macrophages and to investigate the correlation between LPSinduced activation of macrophages and LPS-induced cytotoxicity toward macrophages, we isolated LPS-resistant mutants from the J774.1 macrophage-like cell line with altered activated macrophage phenotypes [9, 10] . As shown at the right side of Figure 1 , one of the typical mutants, the LPS1916 cell line [9] , shows very high resistance to LPS with a much reduced ability to produce ROS in response to LPS [9, 11] . Later, as shown at the left side of Figure 1 , we found a novel cytotoxic effect of LPS toward macrophages in the presence of a protein synthesis inhibitor, cycloheximide (CHX), which was proved to be induced without activated macrophage In the right half of the figure, macrophages are activated by LPS; and several hours later, the activated macrophages produce ROS such as 2 O  and NO as well as inflammatory cytokines such as TNF-α or IL-1β, or prostaglandins. These products impair macrophage functions and cause cytotoxicity, leading to apoptotic or nonapoptotic cell death of macrophages. The left half of the figure shows that if CHX is present with LPS, macrophages respond to LPS but rapidly, within a few hours, proceed to apoptotic cell death without showing activated-macrophage phenotypes.
Resistant mutant cell lines were isolated either in the presence of a very high concentration (100 μg/mL) of LPS alone (right side at bottom) or in the presence of 100 μg/mL LPS and 10 μg/mL CHX (left side at bottom), and are designated as the LPS1916 mutant [9] and LCR mutants (present study), respectively.
phenotypes [12] but with altered LPS-signaling, especially with sustained phosphorylation of p38 MAP kinease (p38MAPK; [13] ) and subsequent apoptosis [13] [14] [15] [16] .
In this study, we isolated macrophage mutant, resistant to LPS and CHX-induced macrophage cell death, and investigated these mutant cell lines with respect to the relationships between LPS-resistance and not only activated macrophage phenotypes but also LPS-binding properties including expression of CD14, Toll-like receptor 4 (TLR4), and Myd88 molecules.
MATERIALS AND METHODS

Materials
Escherichia coli 055:B5 LPS, chromatographically purified, was obtained from Sigma (St. Louis, MO.) Ham's F12 medium was purchased from Flow Laboratories (McLean, VA); and fetal bovine serum (FBS) containing less than 60 pg LPS per mL, from GIBCO (Grand Island, NY). Both were used throughout these experiments. Na 125 I was purchased from ICN Biochemicals (Irvine, CA). Recombinant murine IFN-γ was a generous gift from TORAY (Tokyo, Japan). All other reagents and chemicals were of the purest commercial grade available.
Cell Culture and Isolation of LPS-Resistant Mutants
JA-4, a subline of a murine macrophage-like cell line J774.1 [9] , was used as the parental, wild-type cell line throughout this study. JA-4 cells were cultured in Ham's F-12 medium containing 50 U of penicillin and 50 μg of streptomycin per mL, and 10% (v/v) heat-inactivated FBS (GIBCO, Grand Island, NY) in a CO 2 incubator (5% CO 2 -95% humidified air) at 37˚C. Isolation of clones resistant against LPS + CHX-induced cell death was performed essentially as described previously [9] . In brief, mutagenesis of the parental JA-4 cells was done by incubation of the cells (5 × 10 5 cells/10 mL) at 37˚C for 18 h in T-75 flasks (Corning/Iwaki Glass, Tokyo, Japan) containing 10 mL of fresh medium and 400 μg of ethyl methane sulfonate (EMS; Sigma). Then the cells were rinsed 3 times with medium lacking EMS and incubated at 37˚C for 6 h in 10 mL of fresh medium containing 100 ng/mL LPS + 10 μg/mL CHX, under which conditions almost all of the non-treated JA-4 cells died. For selection of LPS + CHX-resistant mutants, the surviving cells were detached by trypsinization, reseeded at 1 × 10 6 cells/100-mm-diameter dish per 10 mL of medium, and then incubated at 37˚C for several days to allow the cells to grow and form stable colonies on the dishes. At this stage, the frequency of LPS + CHX-resistance was about 8.1 × 10 -4 . Fourteen clones were picked up from these stable colonies by trypsinization in steel rings, and maintained in the medium. Finally, the 14 clones were individually seeded onto 100 mm-dishes and stable sublines were isolated from each dish and designated as LCR-1 to LCR-14. After estimation of the LPS dosedependent resistance in the presence of 10 μg/mL CHX, LCR-1, 3, 4, 10 and 11 clones were used as LCR mutants (Figure 1 , left side, bottom) throughout this study. All of these cell clones were stored frozen in a liquid nitrogen tank before use, and were thawed and maintained in nonselective medium for at least 1 week before assays.
Assays for LPS + CHX-Resistance and LPS-Resistance
Resistance to LPS + CHX-induced cell death was quantitatively estimated as described before [12] . In brief, 2 × 10 5 cells were seeded into the wells of a 24-well clustered microplate (Costar, Cambridge, MA) and incubated at 37˚C for 4 h. Then the medium was replaced with fresh medium containing various concentrations of LPS in the presence or absence of 10 μg/mL CHX, and the cells were incubated at 37˚C for 4 h. The reaction was stopped by sudden chilling of the microplates on ice, after the culture supernatants were collected into microfuge tubes and centrifuged at 11,000 × g for 1 min at 4˚C. The resultant supernatants were collected and assayed for lactate dehydrogenase (LDH) by using an LDH-Cytotoxic Test Wako (Wako Pure Chemicals, Osaka, Japan) according to the manufacturer's protocol. Culture supernatants collected at zero-time incubation were used to determine the background release of LDH. To determine the total LDH activity, cultures of non-treated cells were mixed with a final concentration of 0.1% Triton X-100 at the end of the incubation at 37˚C for 4 h, and then incubated for an additional 30 min at 37˚C for complete lysis of the cells. Cytotoxicity was expressed as % of the total activity according to the following formula:
% of total experimental release background release total activity 100
  
We also examined LPS-resistance of the mutant cells by performing a cell growth assay [9] . In brief, 5 × 10 3 cells were seeded into the wells of a 24-well clustered microplate in 0.5 mL of medium and incubated at 37˚C for 4 h. Then the medium was exchanged for fresh medium containing 0.001 -100 μg/mL LPS, and the cells were incubated at 37˚C for 4 days in a CO 2 incubator. Finally, the medium was removed; and the adherent cells were then detached with 0.5 mL of 0.025% trypsin and 1 mM EDTA in PBS. The cell numbers were counted with a Coulter Counter (Coulter Electronics, Hialeah, FL) as a suspension in Isoton II, and the results were expressed as values (%) relative to the control without LPS addition.
Assays for TNF-α and NO Production
To estimate the activated-macrophage phenotypes of the mutants, we used ELISA [17] and Griess reagents [18] to assess TNF-α release from and NO production by the LPS-treated cells, respectively. In brief, the cells were seeded at 2 × 10 5 cells/0.5 mL/well of a 24-well clustered microplate and incubated at 37˚C for 4 h, after which the medium was replaced with fresh medium containing various concentrations of LPS. The cells were further incubated at 37˚C for 4 h, and the culture supernatants were then collected and centrifuged at 11,000 × g for 1 min at 4˚C. The resultant supernatants were examined for TNF-α content by using an ELISA kit (R & D Systems, Minneapolis, MN), according to the manufacture's protocol. NO production was examined by similarly using the culture supernatants of LPS-treated cells that had been incubated in the presence or absence of 10 U/mL IFN-γ at 37˚C for 24 h, and the amounts of 2 
NO
 were determined with Griess reagents for the nitrite assay (Wako Pure Chemicals). Following mixing of the reaction mixture in a 96-well microplate, the A550 was monitored with a microplate reader (Titertek Multiscan Plus, model MKII), with background subtraction at A630. Quantitative analysis was performed with known standard solutions of NaNO 2 .
FACScan Analysis
The cells were seeded at 4 × 10 6 cells/10 mL/dish (Iwaki #3000-035, Tokyo, Japan), and then incubated at 37˚C overnight. Then the cells were rinsed with ice-cold FACScan buffer comprising 0.1% BSA and 0.1% sodium azide in PBS (19) , scraped off from the dish, collected by centrifugation, and washed with FACScan buffer. For the staining of cell-surface antigens, aliquots of 1 × 10 6 cells were incubated on ice with a polyclonal rabbit anti-mouse CD14 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or FITC-conjugated anti-TLR4 antibody (e-Bioscience, San Diego, CA) for 30 min and washed once with 0.5 mL of FACScan buffer by centrifugation at 670 × g for 3 min. Then the cells that had been reacted with anti-mouse CD14 antibody were mixed with FITC-conjugated anti-rabbit antibody and incubated on ice for 30 min. Then the cells were washed again with 0.5 mL of FACScan buffer, finally suspended in 1 mL of the FACScan buffer, and filtered through a 400-mesh nylon cloth. For the staining of the cell interior, aliquots of 1 × 10 6 cells were incubated for 30 min on ice in culture medium (pH 7.5) containing 10% FBS and 3.7% formaldehyde, washed by centrifugation with icecold PBS as described above. The resultant cell pellets were treated with 0.1% Triton X-100 in PBS for 30 min on ice. Next, the cells were washed with PBS by centrifugation and then incubated with either polyclonal rabbit anti-mouse CD14 antibody or polyclonal rabbit anti-Myd88 antibody (Santa Cruz Biotechnology) for 30 min on ice. The subsequent processes of washing, reaction with FITC-conjugated anti-rabbit antibody, and filtration were performed as described above. Every sample for cell surface staining was reacted with 7-amino actinomycin D (7-AAD; e-Bioscience) to eliminate the damaged cells with a leaky membrane barrier, before sorting with a FACScan (Beckton Dickinson Immunocytometry Systems; San Jose, CA). The results were analyzed with the Cell Quest TM Program (BD TEchnologies).
SDS-PAGE/Western Blotting
As described previously [19] , the cells were seeded at 4 × 10 6 cells/10 mL/dish ((Iwaki #3000-035) and incubated at 37˚C overnight. The cells were then chilled on ice and washed twice with PBS, scraped off the dishes, and pelleted by brief centrifugation at 4˚C at 11,000 × g. The cell pellets were suspended in 100 μL of lysis buffer comprising 0.1 mM EDTA, 10 mM NaF, 1 mM Na 3 VO 4 , 1% aprotinin and 0.1% Triton X-100 in 20 mM Tris-HCl, pH 7.5. After having been stood on ice for 30 min, the cells were centrifuged at 11,000 × g for 1 min at 4˚C, and the resultant supernatant was used as the cell extract. For SDS-PAGE/Western blotting, 50 μg aliquots of the cell extracts were treated with the SDS-sample buffer and then boiled at 95˚C for 5 min. Samples were loaded onto a 5% -20% gradient Slab gel (ATTO, Tokyo, Japan), electrophoresed in a discontinuous buffer system of Laemli [20] , and then electro-transferred to an Immobilon PVDF membrane (Millipore, Billerica, MA) at 30 V overnight and then at 100 V for 30 min. After blocking of the filter with 30 mg/mL milk casein (Snow Brand, Sapporo) in a rinse buffer comprising 0.1% Triton X-100, 0.1 mM EDTA, and 0.8% NaCl in 10 mMTris-HCl buffer, pH7.5, the proteins on the filter were reacted with polyclonal rabbit antibody against mouse CD14 (Santa Cruz) at 37˚C for 2 h, and then the membrane filter was rinsed 3 times with the rinse buffer. Next, the membrane was reacted with an HRP-conjugated anti-rabbit IgG (Cell Signaling Technology, Danvers, MA) at room temperature for 1 h. The immune complexes on the membrane were detected by the addition of luminol (Cell Signaling Technology) and H 2 O 2 , according to the manufacturer's protocol. The intensity of the reaction products was determined by use of an LAS2000 image analyzer (Fuji Film, Tokyo, Japan), and the results were analyzed with Multi Gauge v2.2 (Fuji Film, Tokyo, Japan).
Preparation of [ 125 I]-LPS and Binding of [ 125 I]-LPS to Cell Monolayers
[ 125 I]-LPS (E. coli O55:B5) was prepared as described previously [10] by using a variation of the procedure of Ulevitch [21] . The specific activity of the labeled LPS varied from preparation to preparation, ranging from 0.1 to 1.2 μCi/μg LPS; and the approximate mean value was 0.3 μCi/μg LPS. The LPS binding assay was performed according to the method described before [10] with slight modifications. In brief, cells were seeded at 2 × l0 5 cells/well of a 24-well microplate containing 0.5 ml of the culture medium. After preculturing overnight, the medium was changed to that containing 10%FBS, and then the cells were cooled on ice at 4˚C for 15 min. Next, the cells were incubated with 100 ng/mL [ 125 I]-LPS in the presence or absence of 5 μg/mL of non-labeled LPS at 4˚C for 6 h. The binding incubations were terminated by rapid and repeated washing 3 times of each well with 0.5 mL of the buffers, composed of 0.02% (w/v) BSA in PBS. Finally, the cells were lysed with 0.5 mL of 0.1 N NaOH and transferred to a counting tube, and then the radioactivity was measured with an auto-well γ-counter (Aloka, Tokyo, Japan). The results were expressed as specific binding activity of LPS (ng/well/2 × l0 5 cells) after calculation by subtraction of non-specific activity (radioactivity bound in the presence of 5 μg/mL nonlabeled LPS) from the total activity (radioactivity bound in the absence of 5 μg/mL of non-labeled LPS).
Morphologic Observation
Cells were observed under a phase-contrast microscope (Diamat; Nikon, Tokyo, Japan), and photographs were taken with black and white film (Neopan F; Fuji Film, Tokyo, Japan) with a Nikon FE camera.
RESULTS
Resistance of Mutant Cells against the LPS and CHX-Induced Cytotoxicity
We examined the resistance of the mutant cell lines against the LPS and CHX-induced cytotoxicity. LCR-1 and LCR-3 cell lines, representative LCR mutant cell lines isolated by using a somatic cell genetics protocol to select for cells resistant to LPS and CHX-induced cytotoxicity (Figure 1 , left side at bottom), showed little change after incubation with 100 ng/mL LPS + 10 μg/mL CHX (Figures 2(f) and (h) ). However, the JA-4 cell line, i.e., the parental, wild-type cell line, exhibited severe cell damage including evidence of apoptosis as well as a swollen, necrotic morphology under the same conditions (Figure 2(b) ). The LPS1916 cell line, isolated previously [9] by its resistance to high-dose LPS (Figure 1 , right side at bottom) showed little cell damage after LPS + CHX-treatment (Figure 2(d) ). However, all of these cell lines showed intact cell morphology with adherent and a round shape, if the cells were incubated without LPS + CHX-treatment (Figures 2(a), (c) , (e) and (g)). Similar results were obtained with other LCR mutants, i.e., LCR-4, 10 and 11 in the presence or absence of LPS + CHX (data not shown). These results show that the LCR mutant cell lines, as well as the LPS1916 cell line, were resistant to the cytotoxic effects of LPS + CHX on macrophages [12] .
To examine the extent of the resistance of LCR mutants quantitatively, we next examined the LPS dosedependent release of LDH in the presence or absence of CHX (Figure 3) . JA-4 cells released LDH dependent on the LPS dose in the presence of CHX. They released significant amounts of LDH at and more than 1 ng/mL LPS, and exhibited maximal release of around 66% at and more than 10 ng/mL (Figure 3(a) ). However, none of the LCR mutants or LPS1916 cells showed LDH release in the presence of CHX, even at 1000 ng/mL LPS. In the absence of CHX, JA-4, LCR, and LPS1916 cell lines showed no LDH release in response to LPS (Figure  3(b) ), indicating that LCR mutant cell lines had acquired high resistance to LPS + CHX-induced macrophage cell death.
Because the resistance of the LCR mutants seemed to be primarily LPS-resistance based on the results of the LPS dose-response study shown in Figure 3 , we next examined the LPS-resistance of these mutants not by the short-term incubation in the presence of CHX (Figure  3(a) ), but by the long-term incubation with LPS alone at higher doses (Figure 4) ). LPS showed growth inhibition of the macrophage cell lines, and the JA-4 cell line was the most sensitive to LPS, whereas the LPS1916 cell line showed the highest resistance to LPS among the cell lines. All of the LCR mutants showed resistance to LPS intermediate between that of JA-4 and LPS1916 cell lines. The IC 50 value of LPS, meaning inhibition of cell growth to 50% of the non-treated control without LPS, of the JA-4 parental cell line but that the extent of their resistance was less than that of the LPS1916 cell line, which was isolated not by resistance to the LPS + CHXinduced cytotoxicity but by that to high-dose LPS, suggesting the enhancing effects of CHX on the susceptibility of macrophages to the LPS-induced cell death during the short-term culture.
Secretion of TNF-α
We next examined the activated macrophage phenotypes that appeared in response to LPS. Secretion of TNF-α is one of the most remarkable phenotypes of activated macrophages [1] . As shown in Figure 5 , JA-4 cells secreted TNF-α dependent on the LPS dose, and 1 ng/mL LPS induced significant amounts of TNF-α. On the contrary, all of the LCR mutants and LPS1916 cells secreted a lesser amount of TNF-α, especially at the low doses of LPS at 1 and 10 ng/mL. These results suggest that LCR mutants were able to be activated by LPS but that the extent of the response and the threshold of it were less and higher, respectively, than those of the parental cell line, JA-4.
Next, the LCR mutants were examined for another phenotype of activated macrophages, i.e., NO production. As shown in Figure 6 , the results in Figure 6 (a) may be thought to correspond to NO production by these macrophages. In the presence of 10 U/mL IFN-γ, not only JA-4 but also the LCR mutants as well as the LPS1916 cells produced 2 , in an LPS dose-dependent manner. However, the extent of 2 NO  NO  production was less in the LCR mutants than in the JA-4 cells, especially at 0.1 μg/mL LPS. These results suggest that the LCR mutants had reduced ability for LPS-responsiveness in terms of NO production.
Binding of [ 125 I]LPS to the Mutant Cells
Because another LPS-resistant mutant, LR-9, shows reduced binding of LPS to the cell surface [10] , we examined the binding of [ 125 I]LPS to the LCR mutants as well as to the LPS1916 and JA-4 cells. As shown in Figure 7 , specific binding of LPS was much lower in the LCR mutants and LPS1916 cell line than in the JA-4 parental cell line. These results suggest that the resistance to LPS both in the presence of CHX during 4 hours' incubation (Figure 3(a) ) and in the absence of CHX during 4 days' incubation (Figure 4) , as well as the reduced responses of the activated-macrophage phenotypes (Figures 5 and  6 ) might have been due to this reduced LPS-binding of the LCR mutants. 
Expression of CD14 in the Mutant Cells
CD14 is known to be involved in the binding of LPS to macrophages, leading to transduction of the LPS-binding signal to the TLR4 receptor systems [1] . Because the LCR mutants showed reduced LPS-binding (Figure 7) , CD14 expression was examined in JA-4, LPS1916, LCR-1, and LCR-3 cells. As shown in Figure 8(a) , the expression of CD14 was remarkable on the surface of JA-4 cells, whereas it was scarcely seen on that of LCR-1 cells (Figure 8(c) ), and significantly reduced in LPS1916 (Figure 8(b) ) and LCR-3 (Figure 3(d) ) cells. These results would seem to explain in part the reason why these mutants showed reduced LPS-binding.
Because CD14 is known to be processed intracellularly from a molecule with high mannose-type oligosaccharide to that of the mature-type one [22] , we next examined the distribution of CD14 inside of the cells. As shown in Figures 8(e)-(h) , all of the cells examined exhibited a similar intracellular expression of CD14 molecules, in contrast to the difference in the cell-surface distribution of CD14.
Expression of TLR4 and Myd88 in the Mutant Cells
As LPS signals are transduced via TLR4 and Myd88 [1, 22] , the reduced LPS-responses in terms of both LPSresistance (Figures 3 and 4) and activated-macrophage phe-notypes (Figures 5 and 6 ) might be attributed to the altered expression of TLR4 and/or Myd88. FACScan analysis of cell-surface TLR4 revealed significant expression with very little difference between JA-4cell line and the LCR mutant or LPS1916 cell lines (Figure 9 ). Besides TLR4, intracellular Myd88 expression in JA-4, LPS1916, LCR-1 and LCR-3 cell lines was also examined. As shown in Figure 10 , Myd88 was present significantly and similarly in all 4 of these cell lines. These results suggest that neither TLR4 nor Myd88 was primarily involved in the acquisition of the LPS-resistance or in the reduced LPS responses concerning activatedmacrophage phenotypes.
Analysis of Molecular Sizes of CD14 Expressed in the Mutant Cells
The results in Figure 8 suggest that CD14 in the LCR mutants and LPS1916 cells was poorly expressed on the cell surface but was abundant inside of the cells. Therefore, there might be a possibility that the process of CD14 maturation was somehow defective in these LCR mutant cells and LPS1916 cells. Analysis of these cell extracts and subsequent immune-detection of CD14 by SDS-PAGE/Western blotting revealed that JA-4 cells expressed CD14 molecules with a molecular weight higher than 50 kDa, whereas the LCR mutants and LPS1916 cells showed a smaller molecule (Figure 11) . These results suggest that processing of CD14 molecules was normal in the JA-4 cells but that that of the LCR mutants and LPS1916 cells might have been suspended at or before transition steps from the immature type with high-mannose oligosaccharides to the mature type with complex oligosaccharides [22] . These results seem to be in close relationship with the results on CD14 expression (Figure 8) , also suggesting impaired processing of CD14 and inadequate distribution on the cell surface of the LCR mutants and LPS1916 cells.
lished by resistance to 100 μg/mL LPS alone [9] , these LCR mutants showed significantly less resistance to LPS-induced cell growth inhibition than LPS1916 cells (Figure 4 ) in the absence of CHX. These results suggest that the stringency of the selection force of the mutant clones after mutagenesis of JA-4 cells with EMS was different between 100 μg/mL LPS alone in the previous study [9] and 100 μg/mL LPS + 10 μg/mL CHX in the present study. This is because the frequency of LPS resistance in the previous study was about 1.5 × 10 -5 , whereas that of LPS + CHX-resistance in the present study was 8.1 × 10 -4 . However, LPS-activated macrophage phenotypes of the LCR mutants and LPS1916 cells were similarly reduced as compared with those of the wild-type, JA-4 cell line, concerning LPS-induced TNF-α release ( Figure 5 ) as well as LPS-induced NO production in the presence or absence of IFN-γ (Figure 6 ). These results suggest that the LCR mutants had the common properties of declined or reduced LPS-responses in terms of either LPS-resistance or LPS-induced macrophage activation. Although we found 2 distinct pathways of LPS-induced macrophage cytotoxicity, either through macrophage activation (Figure 1, right) or through apoptotic cell death processes without macrophage activation in the presence of CHX (Figure 1, left) , the resultant resistant mutants in these two pathways, either the LPS1916 cell line (Figure  1, right) , or the LCR mutants (Figure 1, left) seem to have exhibited altered reduced LPS responses in common.
DISCUSSION
In this report, we described the isolation of macrophage mutants, resistant to LPS + CHX-induced cell death, from JA-4 as the parental cell line, which had originated from a macrophage-like cell line, J774.1 [9] by using somatic cell genetics, and designated them as LCR mutants. The mutants showed little damage to their morphology after treatment with LPS + CHX at 37˚C for 4 h (Figure 2) , and released little LDH in response to LPS even at a dose of 1000 ng/mL in the presence of 10 μg/mL CHX (Figure 3(a) ). Although these phenotypes indicating resistance to LPS were also observed in the LPS1916 cell line, which had been isolated and estabIn order to understand the mechanisms underlying the resistance of these mutants to LPS, we examined characteristics of both the LCR mutants and LPS1916 cells in Figure 11 . Analysis of molecular sizes of CD14 expressed in the mutant cells. JA-4, LPS1916, and LCR mutant cells were collected, washed, and extracted as described in the text. Fifty-microgram aliquots of the cell extracts were analyzed by SDS-PAGE/ Western blotting using a polyclonal anti-mouse CD14 antibody, as described in the text. The results shown are images of chemiluminescence detected with the LAS2000 image analyzer, as described in the text. Note that none of the extracts of LCR mutants or LPS1916 cells yielded CD14 bands corresponding to a molecular weight larger than 50 kDa, which was evident in the JA-4 parental cell line. this study. The results in Figure 7 showed reduced binding of LPS to these mutants as compared with the binding to the parental cell line, JA-4. Besides, the expression of CD14 molecules on the cell surface was significantly reduced in both the LCR mutants and LPS1916 cell line, despite the fact that the intracellular distribution of CD14 molecules in these mutants was similar to that of the parental cell line (Figure 8) , supporting the idea that CD14 participated in the accumulation of LPS-LPS binding protein complexes on the cell surface, and in the efficient subsequent transfer of these complexes to TLR4 receptors [24] .
Contrary to the difference in distribution of CD14 on the cell surface of the mutants and JA-4 cells, TLR4 and Myd88 were similarly expressed in these mutants and JA-4 cells (Figures 9 and 10) . These results suggest that the LPS-resistance of the macrophage cell lines might have been acquired through altered CD14 expression or malfunction of CD14, resulting in reduced cell surface expression and a decrease in LPS binding, as was shown in Figure 7 . It should be noted that TLR4 and Myd88 in the mutants showed the same distribution as seen in the pa-rental cells, resulting in the retention of such LPS-responses as TNF-α release and NO production at high doses of LPS at and more than 100 μg/mL (Figures 5  and 6) .
In addition to the altered cell-surface distribution of CD14 in these mutants compared with that in the JA-4 cells (Figure 8) , the size of the CD14 molecule was quite different between these mutants and JA-4 cells ( Figure  11) . Whereas the molecular weight of the CD14 of JA-4 cells ranged from 44 to 55 kDa, the range in the LCR mutants was lower, i.e., 40 -48 kDa; and the molecular weight in the LPS1916 cells was, about 48 kDa. There were no bands higher than 50 kDa in the case of the LCR mutants and LPS1916 cells. It is known that processing of CD14 is accompanied by carbohydrate modifications and that immature CD14 molecules have high mannosetype oligosaccharides with lower molecular weights, whereas mature CD14 has complex-type oligosaccharides of high molecular weight [22] .
Taken together, the results in the present study suggest that macrophages would acquire LPS-resistance, selected by either a very high dose of LPS or LPS + CHX, due to interrupted processing of CD14 molecules with high mannose-type oligosaccharides at the immature stage, thus preventing maturation to CD14 with complex-type oligosaccharides. Such interruption would result in decreased transport to and expression of mature CD14 molecules on the cell surface, with the consequence being decreased sensitivity of macrophages to LPS. Although the LPS-signaling cascades and molecular mechanisms underlying the signal transduction through TLR-4 have been extensively studied and reported, the role of CD14 molecules in the acquisition of LPS-resistance by macrophages has not been studied so far. Our present results provide novel insights into LPS-macrophage interactions with respect to LPS-resistance and biodefense against massive infections by Gram-negative bacteria and endotoxin shock [23, 25, 26] .
